McLaren agrees to $7.75 million settlement on opioid drug diversion charges
Print
McLaren Health Care Corp., a 14-hospital health system based in Grand Blanc, has agreed to a $7.75 million civil settlement over the health system s handling of controlled substances in its retail pharmacy program, federal officials said Tuesday.
The settlement resolved allegations that McLaren violated certain provisions of the federal Controlled Substances Act, according to a statement from U.S. attorneys Andrew Birge in the Western Michigan District and Matthew Schneider in the Eastern Michigan District.
It ended an investigation over several years in which employees at multiple McLaren facilities in Michigan were alleged to have diverted drugs from about 2014 to 2019 and violated federal laws, officials said.